CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients
Related Experiment Videos
Current Therapeutic Research, Clinical and Experimental
|April 1, 1970
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Dose-dependent activation of distinct hypertrophic pathways by serotonin in cardiac cells.
American journal of physiology. Heart and circulatory physiology·2009
Nicotine and smoker status moderate brain electric and mood activation induced by ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist.
Pharmacology, biochemistry, and behavior·2006
Successful cerebral aging: clinical and pharmacological approaches to the aging brain.
Journal of psychiatric practice·2005
The history of the psychopharmacology of schizophrenia.
Canadian journal of psychiatry. Revue canadienne de psychiatrie·1997
Investigation of the correlation between serum levels of interleukin-6 and clinical and paraclinical findings in COVID-19 patients.
Current therapeutic research, clinical and experimental·2026
Population pharmacokinetic modeling of adalimumab biosimilar SCT630 and Humira® in healthy participants and patients with moderate to severe plaque psoriasis to establish PK similarity.
Current therapeutic research, clinical and experimental·2026
Glucagon enhances subcutaneous insulin absorption: Pilot experiments in pigs.
Current therapeutic research, clinical and experimental·2026
Prevalence and correlates of antinuclear antibodies in a Japanese community sample: a cross-sectional study.
Current therapeutic research, clinical and experimental·2026
Paclitaxel, carboplatin, and cetuximab induction chemotherapy for locally advanced head and neck squamous cell carcinoma: A retrospective evaluation of treatment outcomes and safety.
Current therapeutic research, clinical and experimental·2026
Potential interactions between creatine supplementation and prescription drugs: a narrative review and evidence-mapping perspective.
Current therapeutic research, clinical and experimental·2026